Table 1 Characteristics of patients with toxigenic C. difficile
From: Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study
Patient | ICU stay, d | Diseases | Collection date | ST | Cladea | MLVA profileb |
|---|---|---|---|---|---|---|
Isolates detected on admission | ||||||
1 | 13 | Cholangitis, bacteremia | November | 2 | 1/HA1 | 316/171/264/280/280/371 |
2 | 19 | Stroke | September | 3 | 1/HA1 | 259/187/329/365/365/117 |
3 | 7 | Systemic EB virus positive T lymphocyte proliferative disease, pneumonia | September | 3 | 1/HA1 | 425/195/243/336/336/455 |
4 | 27 | Pneumonia, Guillain-Barré syndrome | November | 6 | 1/HA1 | ND |
5 | 6 | Septic shock, colon cancer | August | 54 | 1/HA1 | 322/171/286/365/365/117 |
6 | 4 | Gastric cancer, pneumonia | September | 54 | 1/HA1 | 322/171/286/344/344/223 |
Isolates detected on discharge | ||||||
7 | 12 | Pneumonia, uremia | October | 2 | 1/HA1 | 259/164/263/344/344/488 |
8 | 12 | Embedded abdominal wall hernia | August | 37 | 4/A-B+ | 129/336/209/314/314/420 |
9 | 6 | Septic shock, ovian cancer | October | 37 | 4/A-B+ | 129/344/209/294/293/438 |
10 | 10 | Brain glioma | October | 37 | 4/A-B+ | 129/336/209/307/307/421 |
11 | 17 | Liver cirrhosis | November | 37 | 4/A-B+ | 129/367/209/300/300/438 |
12 | 32 | Pancreatitis | November | 37 | 4/A-B+ | 129/336/209/300/300/487 |
13 | 5 | Gangrenous appendicitis, peritonitis | November | 37 | 4/A-B+ | 129/404/209/307/307/454 |
14 | 10 | Pneumonia | August | 54 | 1/HA1 | 276/171/294/365/365/117 |
15 | 29 | Anterior pituitary hypofunction | October | 54 | 1/HA1 | 218/187/294/414/414/117 |
16 | 8 | Pneumonia | September | 103 | 1/HA1 | ND |
Isolates causing CDI | ||||||
17 | 20 | Pancreatitis | September | 3 | 1/HA1 | 292/148/337/351/351/117 |
18 | 12 | Colon cancer | September | 37 | 4/A-B+ | 129/367/209/307/307/454 |
19 | 19 | Liver cirrhosis | November | 37 | 4/A-B+ | 129/367/209/300/300/420 |
20 | 29 | Liver cirrhosis | September | 129 | 1/HA1 | ND |